Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, representing a small update to the page's documentation/versioning rather than a substantive change to the study record.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page now shows a new Revision: v3.6.2 tag and the topic links for Schizophrenia and MedlinePlus Genetics were removed from the related topics section.SummaryDifference0.2%

- Check17 days agoChange DetectedAdds a related topics section with Schizophrenia and MedlinePlus Genetics to the study page, linking the trial to its disease context and a genetics information resource.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page now includes new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and introduces an 'Intervention/Treatment' header as part of a layout update; it also adds a recruitment note 'No longer looking for participants' and a site revision tag 'Revision: v3.6.0'.SummaryDifference0.5%

- Check31 days agoChange DetectedA new page revision tag (v3.5.5) is now shown, replacing the previous v3.5.4. This reflects a platform update rather than any changes to the study details or user-facing content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe study page now includes Schizophrenia as a related topic and adds a related topics section featuring MedlinePlus Genetics.SummaryDifference0.1%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.